Related Experiment Videos
Mood disorders: cardiovascular and diabetes comorbidity
Wayne S Fenton1, Ellen S Stover
1National Institute of Mental Health, National Institutes of Health, DHHS, Bethesda, Maryland 20892-9621, USA. wfenton@mail.nih.gov
Current Opinion in Psychiatry
|May 25, 2006
Summary
Depression frequently co-occurs with cardiovascular disease and diabetes, worsening medical outcomes. Early detection and collaborative care models improve depression treatment in patients with chronic medical conditions.
Area of Science:
- Psychiatry
- Cardiology
- Endocrinology
Background:
- Depression is a common comorbidity with chronic medical conditions like cardiovascular disease and diabetes.
- Understanding the interplay between mood disorders and physical health is crucial for patient outcomes.
Purpose of the Study:
- To review recent findings on depression comorbidity in cardiovascular disease and diabetes.
- To evaluate the prognostic impact of mood symptoms on medical conditions.
- To identify shared biological and psychosocial mechanisms and outline treatment advancements.
Main Methods:
- This is a review article synthesizing current research.
- It examines epidemiological data on depression prevalence in specific medical conditions.
- Mechanistic hypotheses and treatment strategies are summarized.
Main Results:
- Depression affects up to 25% of patients with cardiovascular disease and diabetes.
- Comorbid depression is linked to poorer medical outcomes, including increased mortality and worse disease control.
- Biological (e.g., HPA axis) and psychosocial factors (e.g., adherence) mediate adverse outcomes.
Conclusions:
- Depression, cardiovascular disease, and diabetes are prevalent chronic illnesses, particularly in aging populations.
- Depression is treatable in medically ill patients.
- Collaborative care models enhance depression detection and treatment in primary care settings.
Related Concept Videos
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...